Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
COYA is expected to report earnings to rise 155.56% to -46 cents per share on May 08
Q1'25
Est.
$-0.46
Q4'24
Beat
by $0.22
Q3'24
Beat
by $0.10
Q2'24
Missed
by $0.42
Q1'24
Missed
by $0.06
The last earnings report on March 18 showed earnings per share of -18 cents, beating the estimate of -40 cents. With 25.64K shares outstanding, the current market capitalization sits at 109.38M.